Skip to content

Validation of Noninvasive Blood Pressure Device

Validation of Noninvasive Blood Pressure Device

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04676152
Enrollment
106
Registered
2020-12-19
Start date
2020-10-05
Completion date
2020-11-02
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy, Hypertension, Hypotension

Brief summary

This is a prospective, nonrandomized multi-center study for the investigation of noninvasive sphygmomanometers. The purpose of the study is to validate the clinical performance of the Masimo noninvasive blood pressure device compared to reference auscultatory measurements.

Interventions

DEVICEMasimo Noninvasive Blood Pressure Device

Non-invasive blood pressure device

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age 18 years and older * Site 1; Stage 1 only: Subjects with a history of hypertension (\> 140/85 mmHg) or hypotension (\< 100/60 mmHg) within the last 3 months. Stage 2 only: No criterion for blood pressure * Site 2; Stage 1 and 2: Subjects with systolic blood pressure \< 140/90 mmHg. * Ability to provide informed consent

Exclusion criteria

* Febrile subjects * Subjects displaying respiratory symptoms, or with suspected respiratory illness * Subjects whose skin is not intact, e.g. wounded, in or at the vicinity of the cuff placement site * Subjects with removed axillary lymph nodes or mastectomies * Subjects with peripheral artery disease * Pregnant women (patient reported) * Subjects deemed not suitable for the study at the discretion of the investigator

Design outcomes

Primary

MeasureTime frameDescription
Mean and Standard Deviation of Differences Between Masimo NIBP Device and Manual Sphygmomanometer Measurements.1 hourPerformance will be determined by calculating the mean and standard deviation of the differences between the systolic and diastolic blood pressure measurements obtained from Masimo NIBP device and manual sphygmomanometer.

Countries

United States

Participant flow

Participants by arm

ArmCount
Test Subjects
Masimo Noninvasive Blood Pressure Device: All enrolled subjects will have blood pressure measurements done using the Masimo NIBP device and the noninvasive blood pressure device
106
Total106

Withdrawals & dropouts

PeriodReasonFG000
Overall Studyscreen fail9

Baseline characteristics

CharacteristicTest Subjects
Age, Customized
Age
<=18 years
0 Participants
Age, Customized
Age
>65 years
15 Participants
Age, Customized
Age
Between 18 and 65
88 Participants
Age, Customized
Age
Unknown/Not reported
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Asian
26 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Black or African American
2 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Hispanic or Latino
26 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
More than one race
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Other
1 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
Unkown or Not Reported
3 Participants
Race/Ethnicity, Customized
Race/Ethnicity (NIH/OMB)
White
48 Participants
Region of Enrollment
United States
106 participants
Sex/Gender, Customized
Gender
Female
59 Participants
Sex/Gender, Customized
Gender
Male
44 Participants
Sex/Gender, Customized
Gender
Unknown/Not Reported
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 106
other
Total, other adverse events
0 / 106
serious
Total, serious adverse events
0 / 106

Outcome results

Primary

Mean and Standard Deviation of Differences Between Masimo NIBP Device and Manual Sphygmomanometer Measurements.

Performance will be determined by calculating the mean and standard deviation of the differences between the systolic and diastolic blood pressure measurements obtained from Masimo NIBP device and manual sphygmomanometer.

Time frame: 1 hour

Population: Subjects excluded from analysis were as follows:~* 9 Subjects were screen fails~* 8 Subjects excluded during data analysis

ArmMeasureGroupValue (MEAN)Dispersion
Test SubjectsMean and Standard Deviation of Differences Between Masimo NIBP Device and Manual Sphygmomanometer Measurements.Systolic Blood Pressure-1.23 mmHgStandard Deviation 7.32
Test SubjectsMean and Standard Deviation of Differences Between Masimo NIBP Device and Manual Sphygmomanometer Measurements.Diastolic Blood Pressure-2.67 mmHgStandard Deviation 7.13

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026